Universe Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Universe Pharmaceuticals INC (UPC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Sep 2023Sep 2022Sep 2021Sep 2020
Operating Activities
Net Income-3.67-8.73-6.58-7.9111.327.56
Depreciation & Amortization0.520.490.510.530.450.41
Deferred Income Tax0.000.611.57-0.54-0.670.00
Change in Working Capital-2.27-2.065.676.60-12.69-1.87
Change in Accounts Receivable3.13-1.714.72-1.53-3.87-4.11
Change in Inventory-0.471.64-1.182.70-0.450.89
Change in Accounts Payable-3.130.142.00-1.922.160.64
Change in Other Working Capital-1.79-2.141.338.25-7.81-0.02
Other Operating Activities0.370.191.52-0.53-0.47-0.09
Net Cash from Operating Activities-5.05-9.511.12-1.30-2.066.12
Investing Activities
Capital Expenditures-0.35-0.36-0.04-0.09-13.53-0.05
Acquisitions0.000.000.00-3.810.000.00
Purchases of Investments0.000.000.000.00-15.330.00
Sales/Maturities of Investments0.000.000.000.001.800.00
Other Investing Activities-0.08-0.120.000.00-13.090.00
Net Cash from Investing Activities-0.34-0.36-0.04-3.91-27.06-0.05
Financing Activities
Debt Repayment-5.278.95-10.60-4.27-2.76-1.43
Common Stock Issued15.0025.000.000.0028.750.00
Other Financing Activities0.000.00-3.093.32-3.70-0.44
Net Cash from Financing Activities9.7333.95-1.393.3226.580.47
Summary
Effect of Forex Changes on Cash-0.240.13-0.11-0.470.550.00
Net Change in Cash4.0924.21-0.32-2.37-2.536.88
Cash at Beginning of Period29.505.295.718.0810.060.00
Cash at End of Period33.5929.505.295.718.080.00
Free Cash Flow-5.40-9.871.07-1.40-15.596.06
Supplemental Disclosures
Interest Paid0.290.300.190.200.150.16
Income Taxes Paid0.000.000.862.753.272.17